Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MelatoSomKids: Pediatric Prolonged-release Melatonin for Sleep Disturbances in PTSD
NCT07418554Phase 3Not yet recruiting
- Sponsor
- Strasbourg University Hospital
- Start
- Jan 2027
- Primary completion
- May 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in sleep disorders, post-traumatic stress disorder (PTSD), sponsored by Strasbourg University Hospital. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
sleep disorderspost-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07418554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07418554.